DE3852117D1 - Immunoassay mit Verwendung von nichtmetallischen, kolloidalen Teilchen. - Google Patents

Immunoassay mit Verwendung von nichtmetallischen, kolloidalen Teilchen.

Info

Publication number
DE3852117D1
DE3852117D1 DE3852117T DE3852117T DE3852117D1 DE 3852117 D1 DE3852117 D1 DE 3852117D1 DE 3852117 T DE3852117 T DE 3852117T DE 3852117 T DE3852117 T DE 3852117T DE 3852117 D1 DE3852117 D1 DE 3852117D1
Authority
DE
Germany
Prior art keywords
analyte
immunoassay
metallic
colloidal particles
colloidal non
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3852117T
Other languages
English (en)
Other versions
DE3852117T2 (de
Inventor
David Anthony Yost
John Caro Russell
Heechung Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alere Switzerland GmbH
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of DE3852117D1 publication Critical patent/DE3852117D1/de
Publication of DE3852117T2 publication Critical patent/DE3852117T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/824—Immunological separation techniques
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
DE3852117T 1987-07-09 1988-06-30 Immunoassay mit Verwendung von nichtmetallischen, kolloidalen Teilchen. Expired - Lifetime DE3852117T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/072,084 US4954452A (en) 1987-07-09 1987-07-09 Non-metal colloidal particle immunoassay

Publications (2)

Publication Number Publication Date
DE3852117D1 true DE3852117D1 (de) 1994-12-22
DE3852117T2 DE3852117T2 (de) 1995-03-30

Family

ID=22105464

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3852117T Expired - Lifetime DE3852117T2 (de) 1987-07-09 1988-06-30 Immunoassay mit Verwendung von nichtmetallischen, kolloidalen Teilchen.

Country Status (9)

Country Link
US (1) US4954452A (de)
EP (1) EP0298368B1 (de)
JP (1) JP2708475B2 (de)
KR (1) KR890002667A (de)
AT (1) ATE114191T1 (de)
AU (1) AU608866B2 (de)
CA (1) CA1331560C (de)
DE (1) DE3852117T2 (de)
ES (1) ES2066774T3 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
EP0291194B8 (de) 1987-04-27 2003-10-22 Inverness Medical Switzerland GmbH Immunoassays und Vorrichtungen dafür
US5120643A (en) * 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
NL8702769A (nl) * 1987-11-19 1989-06-16 Holland Biotechnology Werkwijze voor het bepalen in een testmonster van componenten van de reactie tussen een specifiek bindend eiwit en de bijbehorende bindbare stof onder toepassing van ten minste een gemerkte component, werkwijze voor het bereiden van de gemerkte component, en testkit voor de bepaling van immunocomponenten.
AU2684488A (en) 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
US5294370A (en) * 1988-11-15 1994-03-15 Hbt Holland Biotechnology B.V. Selenium or tellurium elemental hydrosols and their preparation
US5348891A (en) * 1988-11-15 1994-09-20 H.B.T. Holland Biotechnology Method for an increased visualization of the reaction product of a specifically binding substance and a corresponding bindable substance and test kit therefor
US6352862B1 (en) 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
US5075078A (en) * 1989-10-05 1991-12-24 Abbott Laboratories Self-performing immunochromatographic device
US5252496A (en) 1989-12-18 1993-10-12 Princeton Biomeditech Corporation Carbon black immunochemical label
KR910014706A (ko) * 1990-01-10 1991-08-31 원본미기재 세척이 필요없는 개량된 이뮤노어세이(immunoassay)장치
US5518887A (en) * 1992-03-30 1996-05-21 Abbott Laboratories Immunoassays empolying generic anti-hapten antibodies and materials for use therein
US5770389A (en) * 1993-09-27 1998-06-23 Abbott Laboratories Apparatus and method for determining the quanity of an analyte in a biological sample by means of transmission photometry
US5851777A (en) * 1996-02-05 1998-12-22 Dade Behring Inc. Homogeneous sol-sol assay
US5795784A (en) 1996-09-19 1998-08-18 Abbott Laboratories Method of performing a process for determining an item of interest in a sample
US5856194A (en) 1996-09-19 1999-01-05 Abbott Laboratories Method for determination of item of interest in a sample
US6103536A (en) 1997-05-02 2000-08-15 Silver Lake Research Corporation Internally referenced competitive assays
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
US20020004246A1 (en) * 2000-02-07 2002-01-10 Daniels Robert H. Immunochromatographic methods for detecting an analyte in a sample which employ semiconductor nanocrystals as detectable labels
US6699722B2 (en) 2000-04-14 2004-03-02 A-Fem Medical Corporation Positive detection lateral-flow apparatus and method for small and large analytes
AU2001270078A1 (en) * 2000-06-23 2002-01-08 Minerva Biotechnologies Corporation Tandem signaling assay
DE10035706C2 (de) * 2000-07-21 2002-11-07 Brahms Ag Verfahren zur selektiven Bestimmung von blockierenden Autoantikörpern gegen den TSH-Rezeptor
US7270959B2 (en) 2001-07-25 2007-09-18 Oakville Hong Kong Company Limited Specimen collection container
US7300633B2 (en) 2001-07-25 2007-11-27 Oakville Hong Kong Company Limited Specimen collection container
US7393696B2 (en) * 2001-09-28 2008-07-01 Aspenbio Pharma, Inc. Bovine pregnancy test
CA2500407C (en) * 2002-10-11 2009-05-26 Zbx Corporation Diagnostic devices
US7560272B2 (en) 2003-01-04 2009-07-14 Inverness Medical Switzerland Gmbh Specimen collection and assay container
US7517495B2 (en) 2003-08-25 2009-04-14 Inverness Medical Switzerland Gmbh Biological specimen collection and analysis system
US7638093B2 (en) * 2004-01-28 2009-12-29 Dnt Scientific Research, Llc Interrupted flow rapid confirmatory immunological testing device and method
US7465587B2 (en) * 2004-12-03 2008-12-16 Genzyme Corporation Diagnostic assay device
US20060292700A1 (en) * 2005-06-22 2006-12-28 Naishu Wang Diffused interrupted lateral flow immunoassay device and method
BRPI0618713B8 (pt) 2005-11-18 2021-07-27 The Government Of The United State Of America Representado Por The Secretary Of The Dept Of Health A cardiolipina modificada e seus usos
US7569396B1 (en) 2006-09-08 2009-08-04 Purplecow Llc Caffeine detection using internally referenced competitive assays
US20080138842A1 (en) * 2006-12-11 2008-06-12 Hans Boehringer Indirect lateral flow sandwich assay
US7919331B2 (en) * 2006-12-21 2011-04-05 Silver Lake Research Corporation Chromatographic test strips for one or more analytes
EP2716656B1 (de) 2007-06-15 2016-10-12 Xiamen University An Hämagglutinin des Vogelgrippevirus Subtyp H5 bindende monoklonale Antikörper und Verwendung dafür
ES2725356T3 (es) 2009-04-29 2019-09-23 Henry M Jackson Found Advancement Military Medicine Inc Anticuerpos monoclonales de ERG2 y su uso terapéutico
WO2010132447A2 (en) 2009-05-11 2010-11-18 Diabetomics, Llc Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
WO2012012500A1 (en) 2010-07-20 2012-01-26 Nurx Pharmaceuticals, Inc. Optical reader systems and lateral flow assays
WO2012012499A1 (en) 2010-07-20 2012-01-26 Nurx Pharmaceuticals, Inc. Optical reader system
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
US8703439B1 (en) 2011-01-31 2014-04-22 Linda Lester Point of care iodine sensor
WO2013119763A1 (en) 2012-02-07 2013-08-15 Intuitive Biosciences, Inc. Mycobacterium tuberculosis specific peptides for detection of infection or immunization in non-human primates
DE102012013888A1 (de) 2012-07-09 2014-05-22 Schebo Biotech Ag Testkit (Kombi-Schnelltest) zum synchronen Nachweis von Biomarkern im Stuhl zur Erkennung pathologischer Veränderungen im Gastrointestinaltrakt, insbesondere im Darm
DE202012012084U1 (de) 2012-07-09 2013-04-15 Schebo Biotech Ag Testkit (Kombi-Schnelltest) zum synchronen Nachweis von Biomarkern im Stuhl zur Erkennung pathologischer Veränderungen im Gastrointestinaltrakt, insbesondere im Darm
PE20151873A1 (es) 2013-03-14 2016-01-06 Kasing Cheng Sistema de carcasa de tira de prueba
WO2014144292A2 (en) 2013-03-15 2014-09-18 Sanofi Pasteur Biologics , Llc Antibodies against clostridium difficile toxins and methods of using the same
GB2552427A (en) 2015-01-29 2018-01-24 Neogen Corp Methods for immuno chromatographic assay desensitization
KR20180088382A (ko) 2015-10-15 2018-08-03 인바이오스 인터네셔널, 인크. 다중 측면 흐름 분석 시스템 및 이를 이용하는 방법
WO2017150517A1 (ja) 2016-02-29 2017-09-08 富士フイルム株式会社 生体試料中の測定対象物質を定量するためのキット
CN105724428B (zh) * 2016-03-02 2017-02-22 广东省生态环境与土壤研究所（广东省土壤科学博物馆） 一种精准调控水稻镉吸收转运相关基因表达的叶面阻隔剂与应用
CN117203526A (zh) 2020-10-27 2023-12-08 默克专利有限公司 用于检测血吸虫感染的蛋白质
NL2032668B1 (en) 2022-08-02 2024-02-07 Academisch Ziekenhuis Leiden Means for detecting schistosoma infection

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022876A (en) * 1973-06-21 1977-05-10 Stanford Research Institute Mass spectrometric immunoassay
US4122030A (en) * 1977-09-19 1978-10-24 Xerox Corporation Formation of colloidal dispersions of selenium by the locus control method
NL7807532A (nl) * 1978-07-13 1980-01-15 Akzo Nv Metaal-immunotest.
NL8000173A (nl) * 1980-01-11 1981-08-03 Akzo Nv Toepassing van in water dispergeerbare, hydrofobe kleurstoffen als label in immunochemische testen.
US4341757A (en) * 1980-09-02 1982-07-27 Nutrition 21 Stable isotopic immunoassay method employing non-radioactive selenium label
US4645619A (en) * 1985-05-28 1987-02-24 Xerox Corporation Process for the preparation of colloidal dispersions of chalcogens and chalcogenide alloys
JPS62116263A (ja) * 1985-11-15 1987-05-27 Olympus Optical Co Ltd 直線偏光の多重散乱を用いる免疫反応の測定方法および装置
US4927749A (en) * 1986-04-09 1990-05-22 Jeanette Simpson Reagent for cell separation
US5120643A (en) * 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
NL8702769A (nl) * 1987-11-19 1989-06-16 Holland Biotechnology Werkwijze voor het bepalen in een testmonster van componenten van de reactie tussen een specifiek bindend eiwit en de bijbehorende bindbare stof onder toepassing van ten minste een gemerkte component, werkwijze voor het bereiden van de gemerkte component, en testkit voor de bepaling van immunocomponenten.

Also Published As

Publication number Publication date
JPS6435372A (en) 1989-02-06
ES2066774T3 (es) 1995-03-16
DE3852117T2 (de) 1995-03-30
EP0298368A2 (de) 1989-01-11
KR890002667A (ko) 1989-04-11
JP2708475B2 (ja) 1998-02-04
EP0298368A3 (de) 1991-01-09
EP0298368B1 (de) 1994-11-17
US4954452A (en) 1990-09-04
AU1882688A (en) 1989-01-12
ATE114191T1 (de) 1994-12-15
AU608866B2 (en) 1991-04-18
CA1331560C (en) 1994-08-23

Similar Documents

Publication Publication Date Title
DE3852117D1 (de) Immunoassay mit Verwendung von nichtmetallischen, kolloidalen Teilchen.
EP0296724A3 (en) Assay and apparatus using a lateral flow, non-bibulous membrane
NO903124D0 (no) Testmetode og reagenssett for denne.
DE3669206D1 (de) Verfahren zur quantifizierung von zellpopulationen bzw. subpopulationen sowie hierfuer geeignetes reagenz.
ATE57577T1 (de) Immunoassay-methoden unter anwendung von mustern fuer die auffindung von loeslichen antigenen und zelloberflaechenantigenen.
MX164526B (es) Muestra de ensayo irradiada con particulas metalicas dispersas
EP0399184A3 (de) Reagenzien, Verfahren und Testsätze zum Nachweis von Amphetaminen durch einen Fluoreszenz-Polarisations-Immunoassay
JPS6454260A (en) Immunological analysis for ck-mm cardiac infarction
ATE82072T1 (de) Immunoassay und -rolymere igg-derivate zur kompensation von stoerfaktoren in immunoassays.
DE3485303D1 (de) Testverfahren.
EP0290269A3 (de) Immunoassayverfahren und Reagenzien und Herstellungsverfahren der letzteren
ATE81208T1 (de) Verfahren zum nachweis und zur quantitativbestimmung von immunologischen stoffen.
ATE75048T1 (de) Verfahren und apparat zur bestimmung des antikoerperinhalts von blut.
DE3850249D1 (de) Nachweis von analyt in partikel enthaltenden proben.
EP1293780A3 (de) Spezifisches Bindungsanalyseverfahren
JPS5748658A (en) Immunologic measuring method and reagent for measurement
EP0125893A3 (de) Quantitative Bestimmung von Antigenen durch Enzym-Antikörper-Brückenverfahren
ATE67599T1 (de) Heterogenes immunoassay.
ATE174431T1 (de) Entstörungsreagenz für die bestimmung eines analyten mit einem lumineszenzfähigen metallkomplex
ATE173829T1 (de) Turbidimetrisches immunassay mit messung der geschwindigkeit der trübungsveränderung nach dem anfang der immunpräzipitationsreaktion
EP0380019A3 (de) Fluoreszenz-Polarisationsimmunoassay für Methadon
DE3171892D1 (en) Method for detection of oncofetal antigen, for detection of cancer, for evaluation for cancer therapy and diagnostic kit suitable for such purpose
EP0368208A3 (de) Immunoassay-Verfahren und Testsatz dafür
NO175024C (no) Agglutineringsreagens og dets anvendelse for detektering av et antigen, antistoffer eller andre analytter, samt prövesett omfattende reagensen
ATE127588T1 (de) Geminale diphenyl-derivate und ihre verwendung in immunotests.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INVERNESS MEDICAL SWITZERLAND GMBH, ZUG, CH